Literature DB >> 21454965

Natural killer cell activation secondary to innate pattern sensing.

Tsukasa Seya1, Jun Kasamatsu, Masahiro Azuma, Hiroaki Shime, Misako Matsumoto.   

Abstract

Recent progress in understanding the outcomes of pattern-recognition by myeloid dendritic cells (mDC) allows us to delineate the pathways driving natural killer (NK) cell activation. Mouse mDC mature in response to microbial patterns and are converted to an NK cell-activating phenotype. The MyD88 pathway, the Toll/IL-1 receptor homology domain-containing adaptor molecule (TICAM)-1 (TRIF) pathway, and the interferon (IFN)-β promoter stimulator 1 (IPS-1) pathway in mDC participate in driving NK activation, as shown by analyses in knockout mice. Studies using synthetic compounds for Toll-like receptors/RIG-I-like receptors have demonstrated that mDC-NK cell contact induces NK cell activation without the participation of cytokines in mice. In vivo bone marrow transplantation analysis revealed that the IPS-1 pathway in nonmyeloid cells and the TICAM-1 pathway in mDC are crucial for dsRNA-mediated in vivo NK activation. These results infer the presence of cytokine-dependent and cytokine-independent modes of NK activation in conjunction with innate immune activation. Here, we focus on the IFN-inducing pathways and mDC-NK contact-induced NK activation and discuss the reported various NK activation modes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454965     DOI: 10.1159/000326891

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  10 in total

1.  Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.

Authors:  Tolga Sutlu; Sanna Nyström; Mari Gilljam; Birgitta Stellan; Steven E Applequist; Evren Alici
Journal:  Hum Gene Ther       Date:  2012-09-10       Impact factor: 5.695

Review 2.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

3.  Enhancement of antigen-specific immunoglobulin G responses by anti-CD48.

Authors:  Dorothy Yuan; Yuhong Guo; Suwannee Thet
Journal:  J Innate Immun       Date:  2012-11-27       Impact factor: 7.349

4.  Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.

Authors:  Lucas Souza Ferreira; Deivys Leandro Portuondo; Marisa Campos Polesi; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2018-08-14       Impact factor: 7.397

5.  A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.

Authors:  L Martínez-Gil; P H Goff; R Hai; A García-Sastre; M L Shaw; P Palese
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

6.  Lung epithelial cells are essential effectors of inducible resistance to pneumonia.

Authors:  J O Cleaver; D You; D R Michaud; F A Guzmán Pruneda; M M Leiva Juarez; J Zhang; P M Weill; R Adachi; L Gong; S J Moghaddam; M E Poynter; M J Tuvim; S E Evans
Journal:  Mucosal Immunol       Date:  2013-05-01       Impact factor: 7.313

Review 7.  Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV).

Authors:  Masato Nakai; Hiroyuki Oshiumi; Kenji Funami; Masaaki Okamoto; Misako Matsumoto; Tsukasa Seya; Naoya Sakamoto
Journal:  Sensors (Basel)       Date:  2015-10-23       Impact factor: 3.576

8.  Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.

Authors:  Marieke C Verweij; Mary Wellish; Travis Whitmer; Daniel Malouli; Martin Lapel; Stipan Jonjić; Juergen G Haas; Victor R DeFilippis; Ravi Mahalingam; Klaus Früh
Journal:  PLoS Pathog       Date:  2015-05-14       Impact factor: 6.823

9.  RIG-I activation induces the release of extracellular vesicles with antitumor activity.

Authors:  Juliane Daßler-Plenker; Katrin S Reiners; Jasper G van den Boorn; Hinrich P Hansen; Bastian Putschli; Sabine Barnert; Christine Schuberth-Wagner; Rolf Schubert; Thomas Tüting; Michael Hallek; Martin Schlee; Gunther Hartmann; Elke Pogge von Strandmann; Christoph Coch
Journal:  Oncoimmunology       Date:  2016-08-19       Impact factor: 8.110

10.  The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells.

Authors:  Yohei Takeda; Masahiro Azuma; Ryoko Hatsugai; Yukari Fujimoto; Masahito Hashimoto; Koichi Fukase; Misako Matsumoto; Tsukasa Seya
Journal:  Innate Immun       Date:  2018-05-31       Impact factor: 2.680

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.